Hofseth BioCare ASA Statistics

Total Valuation

LON:0Q6H has a market cap or net worth of GBP 58.08 million. The enterprise value is 70.27 million.

Market Cap	58.08M
Enterprise Value	70.27M

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	411.08M
Shares Outstanding	n/a
Shares Change (YoY)	+3.05%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	201.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.88
PB Ratio	30.08
P/TBV Ratio	34.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.38
EV / Sales	3.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-147.06

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 9.00.

Current Ratio	0.84
Quick Ratio	0.50
Debt / Equity	9.00
Debt / EBITDA	n/a
Debt / FCF	-36.36
Interest Coverage	-6.38

Financial Efficiency

Return on equity (ROE) is -142.28% and return on invested capital (ROIC) is -22.68%.

Return on Equity (ROE)	-142.28%
Return on Assets (ROA)	-17.03%
Return on Invested Capital (ROIC)	-22.68%
Return on Capital Employed (ROCE)	-55.79%
Revenue Per Employee	268,834
Profits Per Employee	-126,946
Employee Count	78
Asset Turnover	0.71
Inventory Turnover	2.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.39% in the last 52 weeks. The beta is 0.57, so LON:0Q6H's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	+10.39%
50-Day Moving Average	3.93
200-Day Moving Average	n/a
Relative Strength Index (RSI)	38.84
Average Volume (20 Days)	71,908

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0Q6H had revenue of GBP 20.16 million and -9.52 million in losses. Loss per share was -0.02.

Revenue	20.16M
Gross Profit	5.45M
Operating Income	-7.75M
Pretax Income	-9.52M
Net Income	-9.52M
EBITDA	-7.17M
EBIT	-7.75M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 5.29 million in cash and 17.38 million in debt, giving a net cash position of -12.08 million.

Cash & Cash Equivalents	5.29M
Total Debt	17.38M
Net Cash	-12.08M
Net Cash Per Share	n/a
Equity (Book Value)	1.93M
Book Value Per Share	0.00
Working Capital	-2.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -261,998 and capital expenditures -215,867, giving a free cash flow of -477,865.

Operating Cash Flow	-261,998
Capital Expenditures	-215,867
Free Cash Flow	-477,865
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 27.04%, with operating and profit margins of -38.44% and -47.22%.

Gross Margin	27.04%
Operating Margin	-38.44%
Pretax Margin	-47.22%
Profit Margin	-47.22%
EBITDA Margin	-35.56%
EBIT Margin	-38.44%
FCF Margin	n/a

Dividends & Yields

LON:0Q6H does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.05%
Shareholder Yield	n/a
Earnings Yield	-16.39%
FCF Yield	-0.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2